PeptiDream Inc. | Mutual Funds
Mutual Funds that own PeptiDream Inc.
Advisers Investment Trust - JOHCM International Select Fund
3,923,738
3.2%
-273,210
2.09%
03/31/2018
Oppenheimer Global Opportunities Fund
3,000,000
2.44%
2,000,000
1.25%
03/31/2018
Legg Mason Funds ICVC - Japan Equity Fund
2,100,000
1.71%
-70,000
5.62%
07/31/2018
JPMorgan Funds - Japan Equity Fund
1,959,900
1.6%
64,700
1.73%
06/30/2018
JOHCM - Global Select Fund
1,578,755
1.29%
197,511
2.11%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
1,443,800
1.18%
22,800
0.08%
07/31/2018
Matthews Japan Fund
1,336,900
1.09%
0
1.12%
06/29/2018
Vanguard Total International Stock Index Fund
1,216,010
0.99%
36,500
0.01%
07/31/2018
JPM Asset JPM The Japan Mother Fund
852,900
0.69%
-177,999
1.91%
03/26/2018
RBC Japanese Equity Fund
760,000
0.62%
86,200
2.98%
12/31/2017
| Address |
3-25-23 Tonomachi
Kawasaki Kanagawa 210
Japan
|
|
Employees
|
- |
| Website |
http://www.peptidream.com |
| Updated |
07/08/2019 |
| PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan. |
